201 related articles for article (PubMed ID: 3768528)
1. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota.
Timmons S; Huzoor-Akbar ; Grabarek J; Kloczewiak M; Hawiger J
Blood; 1986 Nov; 68(5):1015-23. PubMed ID: 3768528
[TBL] [Abstract][Full Text] [Related]
2. Endotoxic lipid A interaction with human platelets. Structure-function analysis of lipid A homologs obtained from Salmonella minnesota Re595 lipopolysaccharide.
Grabarek J; Her GR; Reinhold VN; Hawiger J
J Biol Chem; 1990 May; 265(14):8117-21. PubMed ID: 2335520
[TBL] [Abstract][Full Text] [Related]
3. Modulation of human platelet protein kinase C by endotoxic lipid A.
Grabarek J; Timmons S; Hawiger J
J Clin Invest; 1988 Sep; 82(3):964-71. PubMed ID: 3047171
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of Salmonella minnesota Re595 lipopolysaccharide, lipid A and monophosphoryl lipid A on nitric oxide, TNF-alpha, and IL-6 induction from RAW 264.7 macrophages.
Aybay C; Imir T
FEMS Immunol Med Microbiol; 1998 Nov; 22(3):263-73. PubMed ID: 9848688
[TBL] [Abstract][Full Text] [Related]
5. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of monophosphoryl lipid A homologs obtained from Salmonella minnesota Re595 lipopolysaccharide.
Johnson RS; Her GR; Grabarek J; Hawiger J; Reinhold VN
J Biol Chem; 1990 May; 265(14):8108-16. PubMed ID: 2335519
[TBL] [Abstract][Full Text] [Related]
7. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.
Akbar H; Navran SS; Chang J; Miller DD; Feller DR
Thromb Res; 1982 Aug; 27(4):405-17. PubMed ID: 6293114
[TBL] [Abstract][Full Text] [Related]
9. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation.
Rao AK; Koike K; Willis J; Daniel JL; Beckett C; Hassel B; Day HJ; Smith JB; Holmsen H
Blood; 1984 Oct; 64(4):914-21. PubMed ID: 6089937
[TBL] [Abstract][Full Text] [Related]
10. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
11. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.
van Willigen G; Gorter G; Akkerman JW
Arterioscler Thromb; 1994 Jan; 14(1):41-6. PubMed ID: 8274476
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
13. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa.
Rees RS; Gates C; Timmons S; Des Prez RM; King LE
Toxicon; 1988; 26(11):1035-45. PubMed ID: 3245050
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
Nys M; Cloes JM; Demonty J; Joassin L
J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
[TBL] [Abstract][Full Text] [Related]
16. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
17. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.
Khan N; Farooq AD; Sadek B
Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation by a synthetic hydrophobic polymer, polymethylmethacrylate.
Ware JA; Kang J; DeCenzo MT; Smith M; Watkins SC; Slayter HS; Saitoh M
Blood; 1991 Oct; 78(7):1713-21. PubMed ID: 1912561
[TBL] [Abstract][Full Text] [Related]
19. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists.
Shattil SJ; Budzynski A; Scrutton MC
Blood; 1989 Jan; 73(1):150-8. PubMed ID: 2535942
[TBL] [Abstract][Full Text] [Related]
20. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
